Atlantic International (ATLN) Revenue & Revenue Breakdown
Atlantic International Revenue Highlights
Latest Revenue (Y)
$442.61M
Latest Revenue (Q)
$129.55M
Atlantic International Revenue by Period
Atlantic International Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | $442.61M | 10.27% |
| 2023-12-31 | $401.37M | 510171.81% |
| 2022-12-31 | $78.66K | -62.54% |
| 2021-12-31 | $210.00K | -36.27% |
| 2020-12-31 | $329.50K | -38.20% |
| 2019-12-31 | $533.13K | -31.57% |
| 2018-12-31 | $779.07K | -41.81% |
| 2017-12-31 | $1.34M | 42.47% |
| 2016-12-31 | $939.68K | - |
Atlantic International generated $442.61M in revenue during NA 2024, up 10.27% compared to the previous quarter, and up 83021.15% compared to the same period a year ago.
Atlantic International Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | $129.55M | 20.17% |
| 2024-09-30 | $107.80M | 3.03% |
| 2024-06-30 | $104.64M | 100.00% |
| 2024-03-31 | - | 100.00% |
| 2023-12-31 | - | 100.00% |
| 2023-09-30 | - | 100.00% |
| 2023-06-30 | - | 100.00% |
| 2023-03-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2022-09-30 | - | -100.00% |
| 2022-06-30 | $31.18K | -34.34% |
| 2022-03-31 | $47.48K | 35.80% |
| 2021-12-31 | $34.97K | -31.31% |
| 2021-09-30 | $50.90K | - |
Atlantic International generated $129.55M in revenue during Q4 2024, up 20.17% compared to the previous quarter, and up Infinity% compared to the same period a year ago.
Atlantic International Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| ATLN | Atlantic | $442.61M | $129.55M |
| STIM | Neuronetics | $74.89M | $37.30M |
| PRE | Prenetics Global | $21.74M | $6.41M |
| AVR | Anteris Technologies Global | $2.73M | $556.00K |
| SXTC | China SXT Pharmaceuticals | $1.97M | $939.58K |
| IMDX | Insight Molecular Diagnostics | $1.88M | $518.00K |
| NKTX | Nkarta | - | - |
| SAVA | Cassava Sciences | - | - |
| PEPG | PepGen | - | - |
| MIST | Milestone Pharmaceuticals | - | - |